Time to value
Buying wins on speed: a subscription scribe can be in use in days. A custom build takes weeks to months. If immediate coverage is the priority and fit is secondary, buying leads on this dimension.
Custom Software
Build vs Buy an AI Medical Scribe: How to Decide
The build vs buy AI medical scribe decision comes down to whether an off-the-shelf subscription fits your specialties, EHR, and economics, or whether a custom build you own is the better long-term fit. This page is a decision framework comparing the two paths on cost, control, integration, and specialty fit, rather than a capability overview, which our AI medical scribe development page covers, or a pure pricing breakdown, which our AI medical scribe cost page covers. Taction Software builds custom AI medical scribes, so we have a point of view, but the goal here is an honest comparison. We are a healthcare-focused engineering team, founded in 2013, and every build runs under a signed BAA.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
How build and buy differ for an AI medical scribe
The build vs buy AI medical scribe choice is really a trade-off between speed and fit. Buying a subscription gets you a working scribe quickly with no engineering, but you accept its specialty coverage, its EHR integration, its data terms, and a recurring per-clinician fee. Building a custom scribe takes longer and costs more up front, but you own it, tune it to your specialties and templates, control the data handling, and pay no per-seat fee. Neither is universally right; the correct answer depends on your clinician count, how specialized your documentation is, how deep your EHR integration needs to be, and your time horizon. Below are the six dimensions that most often decide a build vs buy AI medical scribe question.
Cost model and clinician count
Subscriptions are low up front but recur per clinician indefinitely. A build is a larger one-time cost with no per-seat fee. The more clinicians you have and the longer your horizon, the more a build vs buy AI medical scribe analysis favors building.
Specialty and template fit
Off-the-shelf scribes cover common specialties well but may fit niche or highly templated documentation poorly. A custom build is tuned to your specialties and templates, which matters most for specialized practices.
EHR integration depth
Subscriptions integrate with common EHRs in standard ways. A build can integrate deeply with your EHR, including structured-field mapping and custom write-back, which is decisive where standard integration is not enough.
Data control and compliance
Buying means accepting the vendor’s data terms and BAA. Building means you control the data handling, retention, and architecture, which matters more in stricter or more sensitive environments.
Ownership and roadmap control
A subscription evolves on the vendor’s roadmap. A custom build is owned, so you control enhancements and are not exposed to price changes or feature removal, a long-term factor in the build vs buy AI medical scribe decision.
How Taction helps you decide and build
Taction Software approaches the build vs buy AI medical scribe question by scoping your real situation first, then giving an honest recommendation, because building is not always the right call. If a subscription genuinely fits your specialties, clinician count, and integration needs, we will say so. Where a custom build is the better long-term fit, we deliver it on fixed-price tiers so the economics are clear against the subscription alternative. Most engagements start with a Discovery Sprint that models both paths against your numbers, then, if building wins, move into a production-ready build for one specialty before expanding. The result is a decision grounded in your data and, where we build, a scribe you own rather than rent.
Discovery Sprint to model both paths
We start with a Discovery Sprint that models build versus buy against your clinician count, specialties, EHR, and horizon, so the build vs buy AI medical scribe decision rests on your numbers rather than a sales pitch.
Honest build-versus-buy recommendation
If a subscription fits, we say so. We only recommend building where it is the better long-term fit, which keeps the recommendation credible and aligned with your interests.
Fixed-price build economics
Where you build, we deliver on fixed-price tiers, so the one-time cost is clear and directly comparable to the recurring per-seat cost of buying over your time horizon.
Specialty tuning where it matters
If your documentation is specialized, we tune the scribe to your specialties and templates, which is the fit advantage a build has over an off-the-shelf subscription.
Deep EHR integration
We integrate the built scribe deeply with your EHR, including structured-field mapping and custom write-back, going beyond the standard integration a subscription offers.
Ownership and control
The scribe you build is owned, with data handling, retention, and roadmap under your control, which is the core long-term advantage in a build vs buy AI medical scribe decision.
Pricing for a custom AI medical scribe
If the decision lands on building, pricing follows the same fixed-price productized tiers we use across our healthcare AI work, so it is directly comparable to a subscription over your time horizon.
- Discovery Sprint: $45K, 4 weeks, models build versus buy and scopes the build
- Production-Ready build: $95K, scribe for one specialty with EHR write-back
- Pilot-Ready Sprint: $145K, production deployment validated with real clinicians
- Enterprise deployment: $500K+, multi-specialty, multi-site scribe platform
Related work
Explore related Taction scribe services:
FAQs
Frequently asked questions
It depends on your clinician count, how specialized your documentation is, how deep your EHR integration needs to be, and your time horizon. Buying is faster and cheaper up front; building costs more initially but is owned, tuned to your specialties, and carries no per-seat fee. A Discovery Sprint models both against your numbers so the build vs buy AI medical scribe decision is grounded in data.
Buying makes sense when you need coverage quickly, your specialties are common and well served by off-the-shelf tools, your EHR integration needs are standard, and your clinician count is small enough that recurring per-seat fees stay manageable. In that situation, the speed and low up-front cost of a subscription usually outweigh the fit advantages of a build.
Building makes sense when you have a larger clinician count over a multi-year horizon, specialized or heavily templated documentation, deep or non-standard EHR integration needs, or stricter data-control requirements. In those cases the ownership, specialty fit, and absence of per-seat fees tend to outweigh the longer timeline and higher up-front cost.
Not over time. A build is a larger one-time cost, but a subscription recurs per clinician indefinitely. For larger organizations over a multi-year horizon, the total cost of a build can be lower than cumulative subscription fees. The crossover depends on clinician count and horizon, which we model during Discovery.
Yes, and that is a reasonable path. Some organizations buy a subscription to get immediate coverage, then build a custom scribe once they know their requirements and the numbers justify it. A Discovery Sprint can help you time that transition so you are not overpaying on subscriptions past the point where a build pays off.
A Discovery Sprint is four weeks. A production-ready build for one specialty typically follows over the next several weeks, and a pilot-ready deployment validated with real clinicians is scoped around the twelve-week Pilot-Ready tier. Multi-specialty, multi-site rollouts extend from there depending on the number of specialties and integrations.